Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of olmesartan medoxomil/amlodipine 20/5 mg tablet in Chinese healthy adult volunteers
jRCT2080221540Phase 1
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of olmesartan medoxomil + amlodipine in hypertension (HTN), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Pharmacokinetic parameters of olmesartan and amlodipine after single and multiple dosing.
02
Drugs
olmesartan medoxomil + amlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on jRCT2080221540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221540.